Nitric oxide contributes to resistance of the Brown Norway rat to experimental autoimmune encephalomyelitis

American Journal of Pathology

Volumn 166, Issue 1, 2005, Pages 147-157

  Staykova, Maria A ^a   Paridaen, Judith T ^b   Cowden, William B ^c   Willenborg, David O ^a,d  

^a CANBERRA HOSPITAL   (Australia)

^b UTRECHT UNIVERSITY   (Netherlands)

^c Biology and Environment   (Australia)

^d The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL IRON; FREUND ADJUVANT; NITRIC OXIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; IMMUNIZATION; LYMPH NODE; MACROPHAGE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SPLEEN CELL; STATISTICAL SIGNIFICANCE;

EID: 11144248395     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62240-7     Document Type: Article

References (48)

1. Marlatta MA: Nitric oxide: biosynthesis and biological significance. Trends Biochem Sci 1989, 14:488-492
2. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109-142
3. Lowenstein CJ, Snyder SH: Nitric oxide, a novel biologic mesenger. Cell 1992, 70:705-707
4. Nathan CF, Hibbs JB: Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991, 3:65-70
5. Willenborg DO, Staykova MA, Cowden WB: Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review. J Neuroimmunol 1999, 100:21-35
6. Sherman MP, Griscavage JM, Ignarro LJ: Nitric oxide-mediated neuronal injury in multiple sclerosis. Med Hypotheses 1992, 39:143-146
7. Lin RF, Lin TS, Tilton RG, Cross AH: Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J Exp Med 1993, 178:643-648
8. Koprowski H, Zheng YM, Heber-Katz E, Fraser N, Rorke L, Fu ZF, Hanlon C, Dietzschold B: In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci USA 1993, 90:3024-3027
9. Cross AH, Misko TP, Lin RF, Hickey WF, Trotter JL, Tilton RG: Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest 1994, 93:2684-2690
10. MacMicking JD, Willenborg DO, Weidemann MJ, Rockett KA, Cowden WB: Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J Exp Med 1992, 176:303-307
11. Cowden WB, Cullen FA, Staykova MA, Willenborg DO: Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J Neuroimmunol 1998, 88:1-8
12. Ruuls SR, Van Der Linden S, Sontrop K, Huitinga I, Dijkstra CD: Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin Exp Immunol 1996, 103:467-474
13. Zielasek J, Tausch M, Toyka KV, Hartung HP: Production of nitrite by neonatal rat microglial cells/brain macrophages. Cell Immunol 1992, 141:111-120
14. Staykova MA, Cowden W, Willenborg DO: Macrophages and nitric oxide as the possible cellular and molecular basis for strain and gender differences in susceptibility to autoimmune central nervous system inflammation. Immunol Cell Biol 2002, 80:188-197
15. O'Brien NC, Charlton B, Cowden WB, Willenborg DO: Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction. J Immunol 1999, 163:6841-6847
16. O'Brien NC, Charlton B, Cowden WB, Willenborg DO: Inhibition of nitric oxide synthase initiates relapsing remitting experimental autoimmune encephalomyelitis in rats, yet nitric oxide appears to be essential for clinical expression of disease. J Immunol 2001, 167:5904-5912
17. Willenborg DO: Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction. J Immunol 1979, 123:1145-1150
18. Williams RM, Moore MJ: Linkage of susceptibility to experimental allergic encephalomyelitis to the major histocompatibility locus in the rat. J Exp Med 1973, 138:775-783
19. Gasser DL, Palm J, Gonatas NK: Genetic control of susceptibility to experimental allergic encephalomyelitis and the Ag-B locus of rats. J Immunol 1975, 115:431-433
20. Levine S, Sowinski R: Allergic encephalomyelitis in the reputedly resistant Brown Norway strain of rats. J Immunol 1975, 114:597-601
21. Happ MP, Wettstein P, Dietzschold B, Heber-Katz E: Genetic control of the development of experimental allergic encephalomyelitis in rats: separation of MHC and non-MHC gene effects. J Immunol 1988, 141:1489-1494
22. Issazadeh S, Kjellen P, Olsson T, Mustafa M, Holmdahl R: Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specific. Eur J Immunol 1997, 27:1584-1587
23. Peers SH, Duncan GS, Flower RJ, Bolton C: Endogenous corticosteroids modulate lymphoproliferation and susceptibility to experimental allergic encephalomyelitis in the Brown Norway rat. Int Arch Allergy Immunol 1995, 106:20-24
24. Cautain B, Damoiseaux J, Bernard I, Fournie E, van Breda Vriesman P, Druet P, Saoudi A: Non-MHC determined resistance of Brown-Norway rats to develop experimental allergic encephalomyelitis is mediated by the endogenous production of transforming growth factor-beta. Transplant Proc 1999, 31:1602-1603
25. Cautain B, Damoiseaux J, Bernard I, van Straaten H, van Breda Vriesman P, Boneu B, Druet P, Saoudi A: Essential role of TGF-beta in the natural resistance to experimental allergic encephalomyelitis in rats. Eur J Immunol 2001, 31:1132-1140
26. Cautain B, Damoiseaux J, Bernard I, Xystrakis E, Fournie E, van Breda Vriesman P, Druet P, Saoudi A: The CD8 T cell compartment plays a dominant role in the deficiency of Brown-Norway rats to mount a proper type 1 immune response. J Immunol 2002, 168:162-170
27. Eylar EH, Jackson JJ, Rothenberg B, Brostoff SW: Suppression of the immune response: reversal of the disease state with antigen in allergic encephalomyelitis. Nature 1972, 236:74-76
28. Fu Y, Blankenhorn EP: Nitric oxide-induced anti-mitogenic effects in high and low responder rat strains. J Immunol 1992, 148:2217-2222
29. Ozaki A, Fukushima A, Fukata K, Sakamoto S, Taniguchi T, Hashiguch M, Ueno H: Genetic background determines sensitivity to the inhibitory function of NO on T cell proliferation and the amounts of NO production mediated through IFN-gamma. Microbiol Immunol 2002, 46:555-563
30. van der Meide PH, de Labie MC, Botman CA, Aten J, Weening JJ: Nitric oxide suppresses IFN-gamma production in the spleen of mercuric chloride-exposed Brown Norway rats. Cell Immunol 1995, 161:195-206
31. Gasser DL, Newlin CM, Palm J, Gonatas NK: Genetic control of susceptibility to experimental allergic encephalomyelitis in rats. Science 1973, 181:872-873
32. Moore MJ, Singer DE, Williams RM: Linkage of severity of experimental allergic encephalomyelitis to the rat major histocompatibility locus. J Immunol 1980, 124:1815-1820
33. Villas PA, Dronsfield MJ, Blankenhorn EP: Experimental allergic encephalomyelitis and corticosterone studies in resistant and susceptible rat strains. Clin Immunol Immunopathol 1991, 61:29-40
34. Stefferl A, Linington C, Holsboer F, Reul JM: Susceptibility and resistance to experimental allergic encephalomyelitis: relationship with hypothalamic-pituitary-adrenocortical axis responsiveness in the rat. Endocrinology 1999, 140:4932-4938
35. Fournie GJ, Cautain B, Xystrakis E, Damoiseaux J, Mas M, Lagrange D, Bernard I, Subra JF, Pelletier L, Druet P, Saoudi A: Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type-2 and type-1 immune-mediated diseases. Immunol Rev 2001, 184:145-160
36. Savignac M, Badou A, Delmas C, Subra JF, De Cramer S, Paulet P, Cassar G, Druet P, Saoudi A, Pelletier L: Gold is a T cell polyclonal activator in BN and LEW rats but favors IL-4 expression only in autoimmune prone BN rats. Eur J Immunol 2001, 31:2266-2276
37. Vandebriel RJ, Meredith C, Scott MP, van Dijk M, van Loveren H: Interleukin-10 is an unequivocal Th2 parameter in the rat, whereas interleukin-4 is not. Scand J Immunol 2000, 52:519-524
38. Willenborg DO, Fordham S, Bernard CC, Cowden WB, Ramshaw IA: IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 1996, 157:3223-3227
39. Willenborg DO, Fordham SA, Staykova MA, Ramshaw IA, Cowden WB: IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J Immunol 1999, 163:5278-5286
40. Krakowski M, Owens T: Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur J Immunol 1996, 26:1641-1646
41. Duhe RJ, Evans GA, Erwin RA, Kirken RA, Cox GW, Farrar WL: Nitric oxide and thiol redox regulation of Janus kinase activity. Proc Natl Acad Sci USA 1998, 95:126-131
42. Ihle JN: The Janus kinase family and signaling through members of the cytokine receptor superfamily. Proc Soc Exp Biol Med 1994, 206:268-272
43. Taylor-Robinson AW: Inhibition of IL-2 production by nitric oxide: a novel self-regulatory mechanism for Th1 cell proliferation. Immunol Cell Biol 1997, 75:167-175
44. Mattner F, Fischer S, Guckes S, Jin S, Kaulen H, Schmitt E, Rude E, Germann T: The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol 1993, 23:2202-2208
45. Staykova MA, Berven LA, Cowden WB, Willenborg DO, Crouch MF: Nitric oxide induces polarization of actin in encephalitogenic T cells and inhibits their in vitro trans-endothelial migration in a p70S6 kinase-independent manner. FASEB J 2003, 17:1337-1339
46. Stefferl A, Brehm U, Storch M, Lambracht-Washington D, Bourquin C, Wonigeit K, Lassmann H, Linington C: Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. J Immunol 1999, 163:40-49
47. Wood DD, Bilbao JM, O'Connors P, Moscarello MA: Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann Neurol 1996, 40:18-24
48. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000, 47:707-717